All articles tagged: Coronavirus infection, unspecified (B34.2)
HealthDay
28 June at 11.51 AM
CDC Advises Updated COVID Vaccine for Everyone Over 6 Months of AgeAs a summer wave of COVID infections rolls across the country, U.S. health officials have recommended that all Americans over the age of 6 months get one of the updated COVID vaccines when they become available this fall.The recommendation was issued Thurs |
HealthDay
25 June at 12.15 PM
Summer COVID Cases Are Rising Across AmericaAs scorching summer temperatures drive Americans indoors and millions travel for vacations and family gatherings, COVID infections are again climbing, U.S. health officials warned Monday.In evidence that suggests a COVID summer wave is underway, case counts are most likely increasing in 39 states and aren’t declining anywhere in the c |
Evalytics
04 March at 05.48 PM
CDC releases new guidance ending 5-day isolation period for recovering COVID-19 patientsThe CDC shortens isolation for COVID-19 from 10 to 5 days for most patients. This change aims to balance public health with societal needs amid Omicron surge. However, individuals should still wear masks for 5 additional days when around others. |
HealthDay
31 January at 04.46 PM
Prolonged SARS-CoV-2 Risk Varies Across Immunosuppressive ConditionsThe risk for prolonged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) varies across immunosuppressive conditions, according to a study published in the Jan. 24 issue of Science Translational Medicine.Yijia Li, M.D., from Harvard Medical School in Boston, and colleagues performed a detailed viro-immunologic analysis of a |
HealthDay
26 January at 03.56 PM
Declines in CVD Mortality Seen From 2010 to 2019 Reversed in 2020Declines in cardiovascular disease (CVD) seen from 2010 to 2019 reversed in 2020 and remained high through 2022, according to a study published online Nov. 14 in the American Journal of Preventive Medicine.Rebecca C. Woodruff, Ph.D., from the U.S. Centers for Disease Control and Prevention in Chamblee, Georgia, and colleagues describe t |
HealthDay
25 January at 11.03 PM
Meds Rarely Offered for COVID-19 Patients at High Risk for ProgressionMany patients with mild-to-moderate COVID-19 infection at high risk for progression are not offered antiviral medication treatment, according to research published in the Jan. 25 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.Paul A. Monach, M.D., Ph.D., from the VA Boston Cooperativ |
HealthDay
24 January at 11.57 PM
Maternal COVID-19 Vaccination May Reduce Neonatal Respiratory DistressMaternal COVID-19 vaccination is associated with reduced frequency of neonatal respiratory distress (RD), according to a study published online Jan. 24 in Nature Communications.Olivia M. Man, from the David Geffen School of Medicine at the University of California in Los Angeles, and colleagues examined the association between matern |
HealthDay
23 January at 04.12 PM
NIH Investigating COVID-19 Experiments Conducted at Boston UniversityThe U.S. National Institutes of Health is investigating COVID-19 experiments at Boston University that have sparked a media firestorm, with some news outlets alleging that scientists created a "killer" strain of the coronavirus as part of their research. |
Evalytics
22 January at 03.28 PM
Wastewater tests can find mpox, study finds. Expect more bugs to be tracked that wayWastewater testing is effective in detecting infections like mpox, with a 32% likelihood of detection. It's a valuable tool for early disease detection and monitoring, including COVID-19, and will expand to track antibiotic-resistant germs and food poisoning bugs. |
HealthDay
19 January at 04.58 PM
COVID-19 Vaccine Uptake Lagging in Patients With Sickle Cell DiseaseCOVID-19 immunization completion is nearly half for people with versus without sickle cell disease (SCD), according to a research letter published online Jan. 8 in JAMA Network Open.Hannah K. Peng, from the University of Michigan in Ann Arbor, and colleagues assessed COVID-19 immunization coverage among 3,424 Michigan residents wit |
HealthDay
13 January at 12.09 AM
Decrease in Head and Neck Cancer Incidence Seen During PandemicDuring the first year of the COVID-19 pandemic, the incidence of head and neck cancer (HNC) decreased, according to a study published online Jan. 11 in JAMA Otolaryngology-Head & Neck Surgery.Jason Semprini, Ph.D., from the University of Iowa College of Public Health in Iowa City, and colleagues examined the change in localized vers |
HealthDay
12 January at 04.41 PM
Vegetarian Diet Tied to Lower COVID-19 IncidenceA vegetarian diet is associated with a lower incidence of COVID-19 infection, according to a study published online Jan. 9 in BMJ Nutrition, Prevention & Health.Júlio César Acosta-Navarro, M.D., Ph.D., from Universidade de Sao Paulo in Brazil, and colleagues examined whether there is an association between a plant-based or vege |
Evalytics
08 January at 09.25 PM
JN.1 variant makes up a majority of COVID cases in the US. Here's what to knowThe article discusses the emergence of the JN.1 variant, which has become the dominant strain in the United States, raising concerns about its potential impact on COVID-19 cases. |
Evalytics
05 January at 08.32 PM
COVID variant JN.1 listed as ‘variant of interest’ by World Health OrganizationThe World Health Organization has labeled the COVID variant JN.1 as a "variant of interest." While it's not more severe, it accounts for 21% of new cases in the U.S., mainly in the Northeast. Current tests and treatments are still effective, but caution is advised during the holiday season to prevent transmission. |
HealthDay
03 January at 04.59 AM
COVID-19 Pandemic at a Tipping Point: WHOThe pandemic has reached a "transition point," the World Health Organization said Monday. Still, that does not mean the public health emergency of international concern (PHEIC) designation declared by the WHO in January 2020 is over yet. The organization's International Health Regulations Emergency Committee met last week to discuss COVID |
HealthDay
21 December at 11.21 PM
Many U.S. Nursing Home Residents Have Not Been Vaccinated for Flu, COVID-19, or RSV for 2023-24Many nursing home residents and adults have not been vaccinated for influenza, COVID-19, or respiratory syncytial virus (RSV) for the 2023 to 2024 season, according to research published in the Dec. 22 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.Hannah E. Reses, M.P.H., from the C |
HealthDay
28 November at 10.49 PM
Prevalence of COVID-19 Variant BA.2.86 Rising in the United StatesThe U.S. Centers for Disease Control and Prevention is warning of a highly mutated COVID-19 variant, the prevalence of which has tripled in the past two weeks. Now, nearly one in 10 new COVID-19 cases are fueled by the BA.2.86 variant.The variant is spreading the fastest in the Northeast: Just over 13 percent of cases in the New York and New Je |
HealthDay
28 November at 04.54 PM
Fluvoxamine Does Not Shorten Duration of COVID-19 SymptomsFluvoxamine does not reduce duration of COVID-19 symptoms in patients with mild or moderate COVID-19, according to a study published online Nov. 17 in the Journal of the American Medical Association. Thomas G. Stewart, Ph.D., from the University of Virginia in Charlottesville, and colleagues from the Accelerating COVID-19 The |
HealthDay
27 November at 04.31 PM
COVID-19 Vaccination Before Infection Cuts Risk for Long COVIDCOVID-19 vaccination before infection is associated with a reduced risk for post-COVID-19-condition (PCC), according to a study published online Nov. 22 in The BMJ.Lisa Lundberg-Morris, from the University of Gothenburg in Sweden, and colleagues conducted a population-based cohort study to examine the effectiveness of primary COVID-19 v |
HealthDay
15 November at 11.05 PM
Olfactory, Gustatory Dysfunction Decline in Years Following COVID-19The prevalence of olfactory dysfunction (OD) and gustatory dysfunction (GD) declines in the three years after COVID-19 infection, according to a research letter published online Nov. 9 in JAMA Otolaryngology-Head & Neck Surgery.Paolo Boscolo-Rizzo, M.D., from the University of Trieste in Italy, and colleagues estimated the three- |
HealthDay
14 November at 04.26 PM
Virologic Rebound Occurs in ~20 Percent Receiving Nirmatrelvir-RitonavirFor patients receiving nirmatrelvir-ritonavir (N-R) for acute COVID-19, virologic rebound (VR) occurs in about one in five, according to a study published online Nov. 14 in the Annals of Internal Medicine.Gregory E. Edelstein, from Brigham and Women's Hospital in Boston, and colleagues conducted an observational study to compare the fr |
HealthDay
09 November at 04.02 PM
Coadministration of COVID-19, Influenza Vaccines Seems EffectiveCoadministration of the BNT162b2 BA.4/5 bivalent mRNA COVID-19 vaccine (BNT162b2-biv) and seasonal influenza vaccine (SIV) generally has similar effectiveness against COVID-19- and SIV-related outcomes compared with administration of each vaccine alone, according to a study published online Nov. 8 in JAMA Network Open.Leah J. McGrath, |
HealthDay
03 November at 03.46 PM
No Significant Increase Seen in Cystitis Diagnoses During COVID-19 PandemicMore women were diagnosed with interstitial cystitis/bladder pain syndrome (IC/BPS) during than before the COVID-19 pandemic, but the difference was not statistically significant, according to a study published online Sept. 12 in LUTS: Lower Urinary Tract Symptoms.Tahireh Markert, M.D., from Harvard Medical School in Boston, and colleagu |
HealthDay
30 October at 09.22 PM
Infectious Diseases Society of America, Oct. 11-15The annual meeting of the Infectious Diseases Society of America was held this year from Oct. 11 to 15 in Boston and attracted participants from around the world, including scientists, physicians, and other health care professionals. The conference featured education courses and comprehensive educational programs that focused on the latest advances in the d |
HealthDay
30 October at 09.08 PM
COVID-19 Meds Like Paxlovid Will Soon Have Big Price TagsAmericans have been getting COVID-19 treatments such as Paxlovid for free, but that is about to end. The medications will enter the private market this week, the Associated Press reported.The price for a five-day course of Paxlovid, made by Pfizer, will be $1,390. Merck has not confirmed a price for its COVID-19 treatment, Lagevrio, but |
Medical xPress
30 June at 07.40 AM
Decision to offer sedation for often-painful IUD insertion is 'groundbreaking,' health experts sayIntrauterine devices (IUDs) are a highly effective and long-lasting form of birth control placed in the uterus. Research shows that many people who get IUDs experience moderate to intense pain during the insertion. But it wasn't until recently that providers began to acknowledge this and do something about it. |
HealthDay
27 June at 03.19 PM
Immunoglobulin Replacement Therapy Beneficial for Blood CancersImmunoglobulin replacement therapy (IgRT) is associated with reductions in hypogammaglobulinemia, infections, severe infections, and associated antimicrobial use among real-world patients with chronic lymphocytic leukemia (CLL) or non-Hodgkin lymphoma (NHL), according to a study published online June 21 in Blood Advances.Jacob D. Soum |
Medpage Today
26 June at 04.59 PM
When Was the Last Time You Really Talked With Your Patient?My 10 o'clock patient's name is Maria*. Her chart has three "health maintenance" flags that are bright red, indicating that she is more than 3 years overdue for a mammogram, more than 6 years overdue for a Pap smear, and has... |
Medpage Today
23 June at 09.21 PM
Novel Triple-Hormone Agonist Boosts Beta-Cell Function in T2DORLANDO -- An investigational triple-hormone receptor agonist improved metabolic profiles of people with obesity with or without type 2 diabetes, an exploratory biomarker analysis of a phase II trial found. After 36 weeks... |
Medpage Today
22 June at 06.00 PM
Fenofibrate Slows Diabetic Retinopathy ProgressionORLANDO -- The cholesterol drug fenofibrate reduced progression of early eye disease among diabetes patients, the LENS trial showed. The fibrate reduced progression of early diabetic retinopathy or maculopathy by a relative... |
Medpage Today
22 June at 06.00 PM
Preventing Surgical-Site Infections; Drugs Go Head to Head for Ischemic StrokeTTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas Tech University Health Sciences Center... |
Medical xPress
22 June at 05.20 PM
Lawsuit could challenge trust in Ozempic and other popular weight loss drugsThe manufacturers of the most popular weight loss drugs are being challenged in court. |
HealthDay
21 June at 03.38 PM
Overall Prevalence of Being Up-to-Date With Lung Cancer Screening Is LowThe overall prevalence of up-to-date (UTD) lung cancer screening (LCS) was low in 2022, with prevalence increasing with age and number of comorbidities, according to a study published online June 10 in JAMA Internal Medicine.Priti Bandi, Ph.D., from the American Cancer Society in Atlanta, and colleagues estimated the contemporary preval |
Medpage Today
13 June at 06.56 PM
Upping Immunotherapy Activity; A Win for Lung Screening; Looming Drug Price Break?Finding a way to dissociate the activity of effector T cells from regulatory T cells could make immune checkpoint inhibitors more effective in the 60% of melanoma patients who do not benefit or develop resistance to the drugs... |
Medpage Today
08 June at 04.00 PM
Here Are the Top Supreme Court Health Cases to WatchBy early July, the Supreme Court will release its most controversial rulings for the 2023-2024 term. The Court's 6-3 conservative supermajority has already overturned Roe v. Wade, sharply limited affirmative action, expanded... |